Compugen Ltd. (CGEN)
2.48
-0.08
(-3.12%)
USD |
NASDAQ |
Sep 09, 16:00
2.48
0.00 (0.00%)
After-Hours: 19:07
Compugen Shareholders Equity (Quarterly) : 88.73M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 88.73M |
| March 31, 2026 | 95.35M |
| December 31, 2025 | 102.73M |
| September 30, 2025 | 43.83M |
| June 30, 2025 | 50.26M |
| March 31, 2025 | 57.11M |
| December 31, 2024 | 54.91M |
| September 30, 2024 | 60.49M |
| June 30, 2024 | 58.34M |
| March 31, 2024 | 59.68M |
| December 31, 2023 | 65.56M |
| September 30, 2023 | 53.23M |
| June 30, 2023 | 62.00M |
| March 31, 2023 | 69.21M |
| December 31, 2022 | 77.68M |
| September 30, 2022 | 79.82M |
| June 30, 2022 | 90.38M |
| March 31, 2022 | 98.15M |
| December 31, 2021 | 106.69M |
| September 30, 2021 | 98.82M |
| June 30, 2021 | 103.42M |
| March 31, 2021 | 110.86M |
| December 31, 2020 | 119.78M |
| September 30, 2020 | 127.24M |
| June 30, 2020 | 129.47M |
| Date | Value |
|---|---|
| March 31, 2020 | 114.11M |
| December 31, 2019 | 38.32M |
| September 30, 2019 | 41.86M |
| June 30, 2019 | 31.80M |
| March 31, 2019 | 33.28M |
| December 31, 2018 | 37.24M |
| September 30, 2018 | 38.17M |
| June 30, 2018 | 40.55M |
| March 31, 2018 | 30.40M |
| December 31, 2017 | 29.30M |
| September 30, 2017 | 38.00M |
| June 30, 2017 | 47.22M |
| March 31, 2017 | 55.77M |
| December 31, 2016 | 63.52M |
| September 30, 2016 | 70.35M |
| June 30, 2016 | 77.13M |
| March 31, 2016 | 82.89M |
| December 31, 2015 | 89.90M |
| September 30, 2015 | 89.41M |
| June 30, 2015 | 95.41M |
| March 31, 2015 | 100.96M |
| December 31, 2014 | 106.12M |
| September 30, 2014 | 106.32M |
| June 30, 2014 | 98.13M |
| March 31, 2014 | 99.95M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pluri, Inc. | -18.60M |
| Evogene Ltd. | -3.29M |
| Scinai Immunotherapeutics Ltd. | 11.73M |
| CollPlant Biotechnologies Ltd. | 4.886M |
| Regentis Biomaterials Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 138.36M |
| Total Liabilities (Quarterly) | 49.63M |
| Debt to Equity Ratio | 0.0341 |
| Current Ratio | 5.718 |
| Net Debt Paydown Yield | -0.02% |